Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma.

by Huat Chye Lim, John D Gordan
Published 2021-02-01

Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.

by Kimberley J Evason, Macrina T Francisco, Vladislava Juric, Sanjeev Balakrishnan, Maria Del Pilar Lopez Pazmino, John D Gordan, Sanjay Kakar, Jan Spitsbergen, Andrei Goga, Didier Y R Stainier
Published 2015-07-01

Oncogene Mimicry as a Mechanism of Primary Resistance to BRAF Inhibitors

by Martin L. Sos, Rebecca S. Levin, John D. Gordan, Juan A. Oses-Prieto, James T. Webber, Megan Salt, Byron Hann, Alma L. Burlingame, Frank McCormick, Sourav Bandyopadhyay, Kevan M. Shokat
Published 2014-08-01

Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling

by Robin K. Kelley, Nancy M. Joseph, Halla S. Nimeiri, Jimmy Hwang, Laura M. Kulik, Zoe Ngo, Spencer C. Behr, Courtney Onodera, Karen Zhang, Andrea G. Bocobo, Al B. Benson, Alan P. Venook, John D. Gordan
Published 2021-09-01

A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS

by Mary McMahon, Adrian Contreras, Mikael Holm, Tamayo Uechi, Craig M Forester, Xiaming Pang, Cody Jackson, Meredith E Calvert, Bin Chen, David A Quigley, John M Luk, R Kate Kelley, John D Gordan, Ryan M Gill, Scott C Blanchard, Davide Ruggero
Published 2019-09-01